Operating Cash Flow (Statement)

$12.48B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$12.48Bperiod endingJun 30, 2026

AMGN TTM Cash from Operations ($48.80M → $12.48B)

TTM operating cash flow (statement)

High-resolution chart · PNG

AMGN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	1,646,000,000
Mar 31, 2001	1,655,700,000
Dec 31, 2000	1,634,600,000
Sep 30, 2000	1,454,200,000
Jun 30, 2000	1,166,500,000
Mar 31, 2000	1,168,900,000
Dec 31, 1999	1,075,300,000
Sep 30, 1999	1,164,000,000
Jun 30, 1999	1,091,600,000
Mar 31, 1999	949,400,000
Dec 31, 1998	1,041,500,000
Sep 30, 1998	998,800,000
Jun 30, 1998	948,000,000
Mar 31, 1998	963,600,000
Dec 31, 1997	902,900,000
Sep 30, 1997	942,400,000
Jun 30, 1997	897,200,000
Mar 31, 1997	961,400,000
Dec 31, 1996	822,600,000
Sep 30, 1996	770,800,000
Jun 30, 1996	809,900,000
Mar 31, 1996	710,200,000
Dec 31, 1995	773,200,000
Sep 30, 1995	732,300,000
Jun 30, 1995	673,100,000
Mar 31, 1995	571,500,000
Dec 31, 1994	531,900,000
Sep 30, 1994	535,800,000
Jun 30, 1994	550,200,000
Mar 31, 1994	555,400,000
Dec 31, 1993	433,000,000
Sep 30, 1993	331,800,000
Jun 30, 1993	248,900,000
Mar 31, 1993	223,500,000
Dec 31, 1992	292,800,000
Sep 30, 1992	268,900,000
Jun 30, 1992	287,100,000
Mar 31, 1992	194,300,000
Dec 31, 1991	96,100,000
Sep 30, 1991	48,700,000
Mar 31, 1991	13,500,000
Dec 31, 1990	48,800,000
Sep 30, 1990	94,700,000
Jun 30, 1990	64,000,000
Mar 31, 1990	18,700,000